Verrica Pharmaceuticals Inc., a dermatology therapeutics company, engages in the development and commercialization of medications for the treatment of dermatologic diseases in the United States. The company offers YCANTH (VP-102) a drug-dev...
Q2 2026
Aug 12, 2026
Q1 2026
May 12, 2026
FY 2025
Mar 11, 2026
Q4 2025
Q3 2025
Nov 14, 2025
